Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
09/08/2011 | US20110217338 HIV-1 Envelope Based Fragments |
09/08/2011 | US20110217333 Soft gel delivery system for treating poultry |
09/08/2011 | US20110217332 Chimpanzee Adenovirus Vaccine Carriers |
09/08/2011 | US20110217331 Inactivation of Reverse Transcriptases By Azido-diarylpyrimidines |
09/08/2011 | US20110217330 Novel method |
09/08/2011 | US20110217329 Vaccine |
09/08/2011 | US20110217328 Compositions and methods for treating ebola virus infection |
09/08/2011 | US20110217327 Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs |
09/08/2011 | US20110217312 Targeting poly-gamma-glutamic acid to treat staphylococcus epidermidis and related infections |
09/08/2011 | US20110217307 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies |
09/08/2011 | US20110217292 Monoclonal antibodies against hmgb1 |
09/08/2011 | US20110217282 Novel Toxin-Antitoxin System |
09/08/2011 | US20110217273 Composition for Preventing or Treating AIDS Containing Plant Stem Cell Line Derived from Cambium of Panax Ginseng Including Wild Ginseng or Ginseng as Active Ingredient |
09/08/2011 | US20110217268 Therapy or prophylaxis of klebsiella pneumoniae infections with a lytic bacteriophage specifically against the k. pneumoniae |
09/08/2011 | US20110217265 Screening for Inhibitors of HCV Amphipathic Helix (AH) Function |
09/08/2011 | US20110217263 Expansion of haemopoietic precursors |
09/08/2011 | US20110217261 Combination pharmaceutical agents as inhibitors of hcv replication |
09/08/2011 | US20110217249 Compositions and Methods for the Treatment of Skin Diseases and Disorders Using Antimicrobial Peptide Sequestering Compounds |
09/08/2011 | US20110217248 Topical Composition |
09/08/2011 | US20110217244 Compositions and methods for enhancing immune response |
09/08/2011 | US20110217242 Phenol with color |
09/08/2011 | US20110217232 Method for Determination of the Responsiveness of an Individual to Misletoe Lectin |
09/08/2011 | DE102010010360A1 Formulierungen von Taurolidin und Verfahren zu seiner Herstellung Formulations of taurolidine and process for its preparation |
09/07/2011 | EP2363488A1 Postweaning multisystemic wasting syndrome virus from pigs |
09/07/2011 | EP2363487A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
09/07/2011 | EP2363483A2 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents |
09/07/2011 | EP2363479A1 Oligoribonucucleotide for inhibiting the expression of a predefined gene |
09/07/2011 | EP2363478A1 Methods and compositions for inhibiting the function of polynucleotide sequences |
09/07/2011 | EP2363462A1 Novel baculoviral vector |
09/07/2011 | EP2363406A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
09/07/2011 | EP2363404A2 PSMA antibodies |
09/07/2011 | EP2363396A1 Thiophene derivatives as antiviral agents for flavivirus infection |
09/07/2011 | EP2363138A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring periodontal diseases |
09/07/2011 | EP2363137A2 Composition for preventing or treating aids containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as active ingredient |
09/07/2011 | EP2363131A1 Famciclovir For The Treatment Of Recurrent Herpes Labialis Using A One-Day Treatment |
09/07/2011 | EP2362780A1 Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
09/07/2011 | EP2362773A1 Methods for inducing programmed cell death |
09/07/2011 | EP2362725A1 Antiviral supplement formulations |
09/07/2011 | EP2137143B1 Pleuromutilin derivatives for the treatment of diseases mediated by microbes |
09/07/2011 | EP2069301B1 Process for the preparation of pleuromutilins |
09/07/2011 | EP1853583B1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
09/07/2011 | EP1853568B1 Hiv inhibiting 2-(4-cyanophenylamino)pyrimidine derivatives |
09/07/2011 | CN1990475B Substituted benzisoselenazolone compounds and use thereof |
09/07/2011 | CN1903878B Anti SARS virus human source nature antibody IgG Fab section |
09/07/2011 | CN1840204B Lentiviral vectors for the preparation of immunotherapeutical compositions |
09/07/2011 | CN1561230B Antigenic compositions |
09/07/2011 | CN102177178A Anti-IL-12/IL-23 antibodies |
09/07/2011 | CN102177172A Compounds and pharmaceutical compositions for the treatment of viral infections |
09/07/2011 | CN102177141A Bi-1H-benzimidazoles as hepatitis C virus inhibitors |
09/07/2011 | CN102176907A Oral vaccines for producing mucosal immunity |
09/07/2011 | CN102176900A Pharmaceutical compositions and related methods of delivery |
09/07/2011 | CN102174623A Fermentation method and application of yeast engineering bacteria |
09/07/2011 | CN102174569A Protein fishing medicament using rice as bioreactor and preparation method and application thereof |
09/07/2011 | CN102174555A Recombinant expression vector of Hsp65-hIL-2 fusion expression and recombinant strain |
09/07/2011 | CN102174534A S. pneumoniae antigens |
09/07/2011 | CN102174533A Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
09/07/2011 | CN102174518A Main cis-acting element of shrimp white spot syndrome virus (WSSV) iel promoter and transcription factor combined with same and application |
09/07/2011 | CN102174516A Molecular target for diagnosing and treating nasopharyngeal cancer related with Epstein-Barr virus (EBV) infection and application thereof |
09/07/2011 | CN102174477A Hepatitis A virus strain SH and diploid cell adaptation method thereof |
09/07/2011 | CN102174476A Inactivated vaccine for preventing duck virus hepatitis and preparation method thereof |
09/07/2011 | CN102174451A Salmonella pullorum attenuated mutant strain S6702 (OmpR) and construction method thereof |
09/07/2011 | CN102174450A Lactobacillus plantarum for resisting helicobacter pylori infection and application thereof |
09/07/2011 | CN102174444A Method for proliferating H9 subtype avian influenza virus and pasteurella by chick embryos |
09/07/2011 | CN102174438A Deminamicin and preparation method and application thereof |
09/07/2011 | CN102174414A Application of new morchella costata M8-13 liquid fermentation substance to development of health-care products and medicaments |
09/07/2011 | CN102174119A Selenized carrageenan and preparation method thereof |
09/07/2011 | CN102174113A Tag-free tuberculosis fusion protein TB10-TB8 |
09/07/2011 | CN102174112A Tag-free tuberculosis fusion protein TB10-Ag85B |
09/07/2011 | CN102174111A Human interleukin-2 (IL-2)/Fc fusion protein |
09/07/2011 | CN102174108A Internalizing anti-cd74 antibodies and methods of use |
09/07/2011 | CN102174095A Malania oleifera lectin and method for preparing same |
09/07/2011 | CN102174091A Truncated and expressed duck plague virus (DPV) recombinant envelope gI protein and preparation method and application thereof |
09/07/2011 | CN102174090A Swine-origin influenza A virus head protein and preparation method and application thereof |
09/07/2011 | CN102174089A Avian influenza virus head protein as well as preparation method and application thereof |
09/07/2011 | CN102174086A Porcine circovirus type 2 recombinant cap protein and subunit vaccine |
09/07/2011 | CN102174084A Cyclic peptide analogues with thymosin alpha1 activity fragments and polyethylene glycol derivatives thereof |
09/07/2011 | CN102174076A Compounds for proteasome enzyme inhibition |
09/07/2011 | CN102174046A Tetomilast polymorphs |
09/07/2011 | CN102174038A Anti-viral nucleoside for treating viral infections |
09/07/2011 | CN102174027A New crystal form of linezolid and preparation method and application thereof |
09/07/2011 | CN102174018A New crystal form of neticonazole hydrochloride and preparation method thereof |
09/07/2011 | CN102172399A YncD gene knock-out vector for saimonella, preparation method thereof and prepared saimonella attenuated vaccine |
09/07/2011 | CN102172398A Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins |
09/07/2011 | CN102172397A In vivo targeting of dendritic cells |
09/07/2011 | CN102172395A Compositions and methods for treatment of microbial disorders |
09/07/2011 | CN102172375A Traditional Chinese medicine for treating chronic hepatitis |
09/07/2011 | CN102172358A Timicosin compound preparation and preparation method and use thereof |
09/07/2011 | CN102172357A Core 2 glcnac-t inhibitors |
09/07/2011 | CN102172348A Solid oseltamivir phosphate medicinal composition |
09/07/2011 | CN102172262A Enzyme treatment for infection |
09/07/2011 | CN101934031B Bone-strengthening and granulation-promoting paste for treating chronic pyogenic osteomyelitis and aseptic necrosis of femoral head and preparation method thereof |
09/07/2011 | CN101890143B Callicarpa nudiflora galangal composite washing liquid, preparation method and application thereof |
09/07/2011 | CN101850088B Antiviral composition and preparation method thereof |
09/07/2011 | CN101816693B Echinacea purpurea extract powder and preparation method and application thereof |
09/07/2011 | CN101798303B Azole derivatives, preparation method and application thereof |
09/07/2011 | CN101797334B External ointment for treating onychomycosis and paronychia |
09/07/2011 | CN101766650B Washing liquor for operation and method for preparing same |
09/07/2011 | CN101698100B Listeriosis vaccine and preparation method |
09/07/2011 | CN101683351B Application of phlorizin in preparing hepatic or health-care food |
09/07/2011 | CN101670013B Production method of fenugreek foot bacteriostatic spray |